We are living in a time of revolution. We’ve seen the enormous impact of the AI revolution with Large Language Models (LLMs) like ChatGPT, and also the weight loss revolution with GLP-1 agonists like Semaglutide and related obesity drugs. Next in line is the longevity revolution.

At the forefront of this coming revolution we find Dr Gil Blander, a man who as founder and chief scientific officer of InsideTracker has been working on expediting this revolution since 2009, far before it became mainstream. In this fascinating and insightful interview we hear about cutting edge developments in personalised health like HealthGPT, the profound implications of nascent anti-ageing breakthroughs, and how they’ll fuel the upcoming longevity revolution.

InsideTracker analyses users’ blood biomarkers, DNA, and lifestyle data to create tailored heal ...